CTSNet
Published on CTSNet (https://spb-cts.freelock.com)

PCSK9 Inhibition to Reduce Cardiovascular Risk: Tempering Expectations [1]

Submitted by aprotopapas [2] on Fri, 2017-05-12 07:21

A short and readable commentary on monoclonal antibodies and dyslipidaemias, particularly on FOURIER,  SPIRE and ODYSSEY trials

Source name: 
Circulation Research
Resource link: 
http://circres.ahajournals.org/content/120/10/1537 [3]
Taxonomy: 
Clinical Epidemiology [4]
Molecular Biology [5]
Pharmacology 2 [6]
Physiology 2 [7]
Cardiac - Pharmacology [8]
Cardiac - Physiology [9]
Cardiac Guidelines [10]
Coronary Disease - Other [11]
Subspecialty(ies): 
Cardiac [12]
Author(s): 
David D. Waters, Priscilla Y. Hsue
Taxonomy2018 vocabulary term reference: 
Coronary Artery [13]
Source URL:https://spb-cts.freelock.com/jans/pcsk9-inhibition-reduce-cardiovascular-risk-tempering-expectations

Links
[1] https://spb-cts.freelock.com/jans/pcsk9-inhibition-reduce-cardiovascular-risk-tempering-expectations [2] https://spb-cts.freelock.com/home/aprotopapas [3] http://circres.ahajournals.org/content/120/10/1537 [4] https://spb-cts.freelock.com/taxonomy/clinical-epidemiology [5] https://spb-cts.freelock.com/taxonomy/molecular-biology [6] https://spb-cts.freelock.com/taxonomy/pharmacology [7] https://spb-cts.freelock.com/taxonomy/physiology [8] https://spb-cts.freelock.com/tags/cardiac-pharmacology [9] https://spb-cts.freelock.com/tags/cardiac-physiology [10] https://spb-cts.freelock.com/taxonomy/cardiac-guidelines [11] https://spb-cts.freelock.com/taxonomy/coronary-disease-other [12] https://spb-cts.freelock.com/categories/cardiac [13] https://spb-cts.freelock.com/taxonomy2018/coronary-disease